BIOMARIN PHARMACEUTICAL INC Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for May 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 38.59 | 15,000 | 578,850 | 0 | |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 38.59 | 15,000 | 578,850 | 51,310 | 36.3 K to 51.3 K (+41.31 %) |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 0 | |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.66 | 18,750 | 1,662,356 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 18,750 | |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.13 | 18,750 | 1,671,131 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 37,500 | |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 56,250 | |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.29 | 18,750 | 1,655,434 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.22 | 18,750 | 1,672,851 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 89.50 | 2,450 | 219,275 | 15,396 | 17.8 K to 15.4 K (-13.73 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Grant | A | 68.78 | 287 | 19,740 | 17,846 | 17.6 K to 17.8 K (+1.63 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 75,000 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 93,750 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.42 | 18,750 | 1,657,856 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.59 | 18,750 | 1,679,794 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 68.78 | 309 | 21,254 | 290,600 | 290.3 K to 290.6 K (+0.11 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 75,000 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 93,750 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.42 | 18,750 | 1,657,856 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.59 | 18,750 | 1,679,794 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 68.78 | 309 | 21,254 | 290,600 | 290.3 K to 290.6 K (+0.11 %) |
| May 09 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 85.96 | 309 | 26,562 | 52,914 | 53.2 K to 52.9 K (-0.58 %) |
| May 09 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 68.78 | 309 | 21,254 | 53,223 | 52.9 K to 53.2 K (+0.58 %) |